MedTrace Logo

Growth and Tolerance of Infants Fed Infant Formulas

NCT01808105 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 424

Last updated 2014-06-02

No results posted yet for this study

Summary

To evaluate growth and tolerance of healthy term infants fed experimental infant formulas, a commercial infant formula and human breast milk.

Conditions

  • Growth and Tolerance

Interventions

OTHER

Control Formula

Feeding ad libitum

OTHER

Experimental Formula 1

Feeding ad libitum

OTHER

Experimental Formula 2

Feeding ad libitum

OTHER

Human Milk

Feeding ad libitum

Sponsors & Collaborators

  • Abbott Nutrition

    lead INDUSTRY

Principal Investigators

  • Jennifer Williams, MPH · Abbott Nutrition

Study Design

Allocation
RANDOMIZED
Masking
TRIPLE
Model
PARALLEL

Eligibility

Max Age
5 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2014-02-28
Completion
2014-02-28

Countries

  • United States
  • Puerto Rico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01808105 on ClinicalTrials.gov